Wild-type, BRAF−/− and CRAF−/− MEFs were generated in previous study [58 (link), 59 (link)]. Melanoma cell lines: MeWo, A101D, Mel-624 were obtained from ATCC.
Recombinant Protein Expression Strategies
Wild-type, BRAF−/− and CRAF−/− MEFs were generated in previous study [58 (link), 59 (link)]. Melanoma cell lines: MeWo, A101D, Mel-624 were obtained from ATCC.
Corresponding Organization : Duke-NUS Medical School
Other organizations : National Cancer Centre Singapore, National University of Singapore, University of Vienna, Max Perutz Labs
Protocol cited in 1 other protocol
Variable analysis
- Mutations generated by PCR and tagged with either FLAG or HA or His
- Cell lines: wild-type, BRAF−/− and CRAF−/− MEFs, MeWo, A101D, Mel-624
- Unspecified, as no measured outcomes are explicitly mentioned
- Vectors used for expression: pCDNA3.1(+) for transient expression, viral vectors (Clontech) for stable expression, and pET-28a (Novagen) for bacterial expression
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!